CAS: 1229453-99-9 - Acrizanib
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Acrizanib REF: IN-DA01FPMBCAS: 1229453-99-9 | 98% | To inquire | Fri 10 Jan 25 |
 | Acrizanib REF: TM-T5373CAS: 1229453-99-9 | 98.71% - 98.72% | 109.00 €~1,281.00 € | Mon 13 Jan 25 |
 | Acrizanib REF: 54-BISN0088CAS: 1229453-99-9 | 99% | 424.00 €~1,159.00 € | Fri 17 Jan 25 |
 | Acrizanib (LHA510) REF: 3D-EZB45399CAS: 1229453-99-9 | Min. 95% | To inquire | Fri 21 Feb 25 |
Ref: IN-DA01FPMB
| 1mg | 178.00 € | ||
| 5mg | 591.00 € | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 10 Jan 2025
Acrizanib
CAS:1229453-99-9
Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.
Formula:
C20H18F3N7O2
Purity:
98.71% - 98.72%
Color and Shape:
Solid
Molecular weight:
445.4
Ref: TM-T5373
| 1mg | 109.00 € | ||
| 5mg | 269.00 € | ||
| 10mg | 414.00 € | ||
| 25mg | 707.00 € | ||
| 50mg | 984.00 € | ||
| 100mg | 1,281.00 € | ||
| 1mL*10mM (DMSO) | 295.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 54-BISN0088
| 1mg | 424.00 € | ||
| 5mg | 715.00 € | ||
| 10mg | 1,159.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
Acrizanib (LHA510)
CAS:1229453-99-9
Acrizanib is a tyrosine kinase inhibitor that has been shown to reduce the growth of …
Formula:
C20H18F3N7O2
Purity:
Min. 95%
Molecular weight:
445.4 g/mol
Ref: 3D-EZB45399
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 21 Feb 2025
